Adia Nutrition

Adia Nutrition (OTCQB: ADIA) launches its second national TV campaign, promoting Adia Med’s stem cell therapies for sports injuries, orthopedic issues, chronic pain, and wound repair at its Winter Park, Florida clinic. Targeting the $25 billion wound care market, Adia Med aims to make regenerative treatments more accessible domestically. The company is in-network with UnitedHealthcare and Aetna, awaiting TRICARE approval. Florida’s SB1768, recognizing stem cell therapy’s benefits, boosts this initiative. The therapies provide alternatives to overseas medical tourism.